Svas Biosana Balance Sheet Health
Financial Health criteria checks 3/6
Svas Biosana has a total shareholder equity of €56.5M and total debt of €54.2M, which brings its debt-to-equity ratio to 95.9%. Its total assets and total liabilities are €148.2M and €91.7M respectively. Svas Biosana's EBIT is €7.4M making its interest coverage ratio 3.1. It has cash and short-term investments of €25.0M.
Key information
95.9%
Debt to equity ratio
€54.16m
Debt
Interest coverage ratio | 3.1x |
Cash | €24.97m |
Equity | €56.49m |
Total liabilities | €91.67m |
Total assets | €148.16m |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: SVS's short term assets (€106.0M) exceed its short term liabilities (€59.7M).
Long Term Liabilities: SVS's short term assets (€106.0M) exceed its long term liabilities (€31.9M).
Debt to Equity History and Analysis
Debt Level: SVS's net debt to equity ratio (51.7%) is considered high.
Reducing Debt: Insufficient data to determine if SVS's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: SVS's debt is not well covered by operating cash flow (17.2%).
Interest Coverage: SVS's interest payments on its debt are well covered by EBIT (3.1x coverage).